Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.97 USD
−76.43 M USD
0.00 USD
15.64 M
About Disc Medicine, Inc.
Sector
Industry
CEO
John D. Quisel
Website
Headquarters
Watertown
Founded
2017
FIGI
BBG00W9MJK79
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. The company was founded in October 2017 and is headquartered in Watertown, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IRON is 65.01 USD — it has increased by 1.88% in the past 24 hours. Watch Disc Medicine, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Disc Medicine, Inc. stocks are traded under the ticker IRON.
IRON stock has fallen by −0.93% compared to the previous week, the month change is a 2.64% rise, over the last year Disc Medicine, Inc. has showed a 10.84% increase.
We've gathered analysts' opinions on Disc Medicine, Inc. future price: according to them, IRON price has a max estimate of 118.00 USD and a min estimate of 70.00 USD. Watch IRON chart and read a more detailed Disc Medicine, Inc. stock forecast: see what analysts think of Disc Medicine, Inc. and suggest that you do with its stocks.
IRON reached its all-time high on Mar 15, 2021 with the price of 190.85 USD, and its all-time low was 11.60 USD and was reached on Mar 1, 2022. View more price dynamics on IRON chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
IRON stock is 5.12% volatile and has beta coefficient of 2.83. Track Disc Medicine, Inc. stock price on the chart and check out the list of the most volatile stocks — is Disc Medicine, Inc. there?
Today Disc Medicine, Inc. has the market capitalization of 1.93 B, it has decreased by −1.83% over the last week.
Yes, you can track Disc Medicine, Inc. financials in yearly and quarterly reports right on TradingView.
Disc Medicine, Inc. is going to release the next earnings report on Mar 28, 2025. Keep track of upcoming events with our Earnings Calendar.
IRON earnings for the last quarter are −0.89 USD per share, whereas the estimation was −1.04 USD resulting in a 14.17% surprise. The estimated earnings for the next quarter are −1.26 USD per share. See more details about Disc Medicine, Inc. earnings.
Disc Medicine, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
IRON net income for the last quarter is −26.60 M USD, while the quarter before that showed −26.35 M USD of net income which accounts for −0.94% change. Track more Disc Medicine, Inc. financial stats to get the full picture.
No, IRON doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 74.00 employees. See our rating of the largest employees — is Disc Medicine, Inc. on this list?
Like other stocks, IRON shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Disc Medicine, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Disc Medicine, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Disc Medicine, Inc. stock shows the buy signal. See more of Disc Medicine, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.